EHRA Premium Access

Single-centre experience of percutaneous left atrial appendage closure using the lifetech lambre device for thromboembolic prevention in patients with atrial fibrillation.

Congress Presentation

About the speaker

Associate Professor Kars Neven

Alfried-Krupp-Hospital Ruttenscheid, Essen (Germany)
3 presentations
0 follower

10 more presentations in this session

Perception on anticoagulant treatment and treatment convenience for patients switching from a vitamin K antagonist to dabigatran for stroke prophylaxis in atrial fibrillation (RE-SONANCE study)

Speaker: Doctor R. Tieleman (Groningen, NL)

Thumbnail

Left atrial appendage occlusion using novel lambre, amulet and watchman in atrial fibrillation

Speaker: Doctor S. Chen (Greifswald, DE)

Thumbnail

Thirty-day clinical outcomes after rhythmology procedures in patients with non-valvular atrial fibrillation on apixaban: Results of the AMPER AF study

Speaker: Professor J. Mansourati (Brest, FR)

Thumbnail

Thirty-day clinical outcomes after an atrial flutter ablation in patients on dabigatran: the STUDY FLUTTER French prospective study

Speaker: Miss D. Mlayeh (Aulnay sous Bois, FR)

Thumbnail

Vitamin-K antagonists vs. NOAC for resolution of left atrial appendage thrombus in patients with atrial fibrillation.

Speaker: Ms N. Kaehler (Berlin, DE)

Thumbnail

Access the full session

Poster session 1 - Atrial Fibrillation - Stroke Prevention

Speakers: Associate Professor K. Neven, Doctor R. Tieleman, Doctor S. Chen, Professor J. Mansourati, Miss D. Mlayeh...
Thumbnail

About the event

Image

EHRA 2019

17 March - 19 March 2019

Sessions Presentations